Manufacturer
CivicaScript
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 21
- Molecules
- 8
- Therapy areas
- 4
CivicaScript is a pharmaceutical manufacturer based in United States. MedsAcross lists 21 of its products across 8 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- CivicaScript LLC, CivicaScript, LLC
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply CivicaScript products through licensed channels, with the documents your regulator needs.
Oncology
14 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Abiraterone 250 mg tabletOralGeneric name | Abiraterone | US FDA | Available on request |
| Abirtega 250 mg tabletOral | Abiraterone | US FDA | Available on request |
| Capecitabine 150 mg tabletOralGeneric name | Capecitabine | US FDA | Available on request |
| Capecitabine 500 mg tabletOralGeneric name | Capecitabine | US FDA | Available on request |
| Temozolomide 100 mg capsuleOralGeneric name | Temozolomide | US FDA | Available on request |
| Temozolomide 140 mg capsuleOralGeneric name | Temozolomide | US FDA | Available on request |
| Temozolomide 180 mg capsuleOralGeneric name | Temozolomide | US FDA | Available on request |
| Temozolomide 20 mg capsuleOralGeneric name | Temozolomide | US FDA | Available on request |
| Temozolomide 250 mg capsuleOralGeneric name | Temozolomide | US FDA | Available on request |
| Temozolomide 5 mg capsuleOralGeneric name | Temozolomide | US FDA | Available on request |
| Yulithira 10 mg tabletOral | Everolimus | US FDA | Available on request |
| Yulithira 2.5 mg tabletOral | Everolimus | US FDA | Available on request |
| Yulithira 5 mg tabletOral | Everolimus | US FDA | Available on request |
| Yulithira 7.5 mg tabletOral | Everolimus | US FDA | Available on request |
Immunology and transplant
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Dimethyl 120 mg delayed-release capsuleOralGeneric name | Dimethyl | US FDA | Available on request |
| Dimethyl 240 mg delayed-release capsuleOralGeneric name | Dimethyl | US FDA | Available on request |
| Fingolimod 0.5 mg capsuleOralGeneric name | Fingolimod | US FDA | Available on request |
Cardiology
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Droxidopa 100 mg capsuleOralGeneric name | Droxidopa | US FDA | Available on request |
| Droxidopa 200 mg capsuleOralGeneric name | Droxidopa | US FDA | Available on request |
| Droxidopa 300 mg capsuleOralGeneric name | Droxidopa | US FDA | Available on request |
Neurology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Dalfampridine 10 mg extended-release tabletOralGeneric name | Dalfampridine | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from CivicaScript
Send a request for any of these products. We confirm the licensed source, documents and lead time.